author-photo

Dorien M. A. Berends-van der Meer

Leiden University Medical Center

8

Papers

1932

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

2016 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (87)
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study

2014 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (35)
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.

2013 Journal of Translational Medicine
Show All
- Source
- Cite
- Save
Citations (124)
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions

2012 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (71)
Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

2010 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (211)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

2009 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (840)
Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (311)
Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (253)